Most people have never heard of vitreomacular traction until a retina specialist points to an OCT scan and shows them the vitreous gel literally tugging on their macula. The result is distorted, blurry central vision in one eye — often mistaken at first for needing new glasses. VMT becomes more common with age because it stems from the normal process of the vitreous gel separating from the retina, which the NEI notes happens to most people as they get older.
The treatment menu is unusually varied here, from watching to injecting to operating. Here’s the cost of each.
What Vitreomacular Traction Is
As you age, the jelly-like vitreous inside your eye shrinks and pulls away from the retina. Usually it detaches cleanly. Sometimes it stays stuck to the macula and keeps tugging — that persistent pulling is VMT, and it can distort vision or even tear the macula into a hole.
| Scenario | What Happens | Typical Approach |
|---|---|---|
| Mild VMT | Small focal traction, minimal symptoms | Monitor with OCT |
| Moderate VMT | Distortion, blur affecting daily life | Ocriplasmin injection or surgery |
| Severe/with hole risk | Progressing toward macular hole | Vitrectomy |
Diagnostic Costs
OCT imaging is essential — VMT is largely an OCT diagnosis because the traction is invisible on a standard exam.
| Diagnostic Step | Cost Without Insurance |
|---|---|
| Retina specialist visit | $250–$450 |
| OCT (retinal cross-section scan) | $75–$200 |
| Repeat OCT monitoring scans | $75–$200 each |
The Three Treatment Paths
VMT is unusual because it has three legitimate paths, and the cheapest one is often the right one. Many cases release on their own, so monitoring at $300–$700 is the default for mild traction. When treatment is needed, you choose between a single ocriplasmin injection (around $4,000, no surgery, but variable success) and a vitrectomy ($8,000–$20,000, more reliable, but it’s surgery). The decision depends on the size of the traction, whether an epiretinal membrane is also present, and how much your vision is affected.
Path 1: Observation ($300–$700)
For mild VMT, watching is standard because spontaneous release is common. You’re paying for periodic OCT scans and visits while your doctor checks whether the vitreous finishes separating on its own.
Path 2: Ocriplasmin Injection ($3,500–$5,000)
A single in-office enzyme injection (Jetrea) can dissolve the sticky attachment in well-selected patients — no operating room required.
| Item | Cost Without Insurance |
|---|---|
| Ocriplasmin drug | $3,000–$4,000 |
| Injection procedure | $300–$600 |
| Pre/post OCT and visits | $200–$500 |
It works best for small, focal traction without an epiretinal membrane. If those conditions aren’t met, success drops, so candidate selection matters.
Path 3: Vitrectomy ($8,000–$20,000)
For larger traction, traction with a membrane, or cases threatening a macular hole, surgery is the most reliable fix. The surgeon removes the vitreous and releases the traction, sometimes peeling membrane at the same time.
| Item | Cost Without Insurance |
|---|---|
| Surgeon’s fee | $2,500–$5,000 |
| Facility/OR fee | $4,000–$12,000 |
| Anesthesia | $800–$2,000 |
| Post-op visits | $500–$1,500 |
This is the same surgery used for a retinal detachment and related vitreoretinal problems, and it carries similar recovery and cataract-formation considerations.
Don’t sit on worsening distortion. VMT can progress to a full-thickness macular hole, which is harder to treat and may leave permanent central vision loss if it’s left too long. If your Amsler grid suddenly shows a worsening or new central blind spot, get rechecked promptly rather than waiting for your next routine appointment. And know that vitrectomy typically leads to a cataract within a year or two, an added cost to plan for.
How to Keep Costs Down
Get an accurate OCT-based diagnosis first so you don’t treat the wrong problem. If you’re a candidate, discuss whether the ocriplasmin injection could spare you surgery entirely. Because everything here bills to medical insurance rather than vision insurance, confirm your specialist and facility are in-network. And keep up with eye exam visits so any traction is caught and tracked early.
Bottom Line
Mild VMT often costs just $300–$700 in monitoring and may resolve on its own. When treatment is needed, an ocriplasmin injection runs about $3,500–$5,000 and a vitrectomy runs $8,000–$20,000 before insurance, or roughly $1,500–$5,000 out of pocket with coverage. The best path depends on the traction’s size and whether a membrane is present — so a precise diagnosis is the most valuable first step.
Frequently Asked Questions
Yes. The AAO notes that a meaningful share of vitreomacular traction (VMT) cases release on their own as the vitreous finishes separating from the retina, which is why mild cases are often just monitored with OCT scans for $300–$700. Surgery or an injection is reserved for cases that cause significant symptoms or threaten to progress to a macular hole.
Ocriplasmin (Jetrea) is an FDA-approved enzyme injected into the eye to dissolve the abnormal attachment causing VMT, avoiding surgery in select patients. It typically costs $3,000–$4,000 for the drug plus the injection. Success isn't guaranteed — it works best for small, focal traction without an epiretinal membrane — so your retina specialist weighs whether you're a good candidate.
Yes — VMT is a medical condition, so monitoring, the ocriplasmin injection, and vitrectomy surgery all bill to medical insurance, not your vision plan. After deductible and coinsurance, surgery out-of-pocket commonly runs $1,500–$5,000. Vision plans like VSP or EyeMed don't cover any of it.